Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hwajin Pharmaceutical is a South Korean pharmaceutical company established in 1983, specializing in the development and manufacturing of finished dosage form medicines. The company maintains a robust portfolio of generic and over-the-counter products focusing on therapeutic areas such as cardiovascular health, gastroenterology, and metabolic disorders. Operating out of a KGMP-certified facility in Hwaseong, Hwajin ensures high standards of quality control and production efficiency. Their business extends beyond the domestic Korean market, engaging in international exports to various regions including Southeast Asia. Hwajin remains committed to enhancing public health through the reliable supply of essential medications and continuous quality improvement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hwajin.